The Prevalence of Hepatitis B Surface Antigen and Hepatitis D Virus Antibody Positivity Among Hemodialysis Patients and Patients With Beta-Thalassemia Major
| Author | Mansooreh Momen-Heravi | en |
| Author | Hasan Afzali | en |
| Issued Date | 2018-04-30 | en |
| Abstract | Background: Patients, who receive hemodialysis and patients with beta-thalassemia major are at great risk for blood-borne viral infections, chiefly different types of hepatitis. Objectives: This study aimed at assessing the prevalence of hepatitis B and D among hemodialysis patients and patients with beta-thalassemia major in Kashan, Iran. Methods: This cross-sectional study was conducted in 2016 on 108 patients on hemodialysis and 34 patients with beta-thalassemia major in Kashan, Iran. After explaining the aim of the study to the participants and securing their informed consents, data on their demographic and health-related characteristics were collected through a questionnaire. Then, a five-milliliter venous blood sample was obtained from each participant and tested using enzyme-linked immunosorbent assay technique for hepatitis B surface antigen and hepatitis D virus antibody. The data were entered in the SPSS program (v. 16.0) and analyzed using the Chi-square and the independent-sample t tests. Results: The prevalence of hepatitis B surface antigen positivity among patients on hemodialysis and patients with beta-thalassemia major was 3.7% and 8.8%, respectively. Moreover, the prevalence of hepatitis D virus antibody positivity among these patients was 2.9% and 1.9%, respectively. The prevalence of hepatitis B surface antigen positivity among patients on hemodialysis had a significant relationship with history of addiction and history of unprotected sex. Conclusions: The prevalence of hepatitis B and D was respectively 3.7% and 8.8% among hemodialysis patients and 2.9% and 1.9% among patients with beta-thalassemia major. Effective strategies should be employed to minimize the risks of hepatitis B and D transmission among hemodialysis patients and patients with beta-thalassemia major. Moreover, regular screening programs are needed for early diagnosis and treatment of viral hepatitis among these patients. | en |
| DOI | https://doi.org/10.5812/modernc.82326 | en |
| Keyword | Hepatitis B Surface Antigen | en |
| Keyword | Hepatitis D Virus Antibody | en |
| Keyword | Hemodialysis | en |
| Keyword | Beta-Thalassemia Major | en |
| Publisher | Brieflands | en |
| Title | The Prevalence of Hepatitis B Surface Antigen and Hepatitis D Virus Antibody Positivity Among Hemodialysis Patients and Patients With Beta-Thalassemia Major | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- mcj-15-2-82326.pdf
- Size:
- 107.42 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF